NCT06673043 - Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions

Lupus Erythematosus, Systemic

Interventions

DRUG

Anifrolumab

Anifrolumab 300 mg concentrate for solution for infusion

Trial Locations (11)

RECRUITING

Research Site, Bydgoszcz

RECRUITING

Research Site, Bytom

RECRUITING

Research Site, Gdansk

RECRUITING

Research Site, Katowice

RECRUITING

Research Site, KRAK W

RECRUITING

Research Site, L DZ

RECRUITING

Research Site, Lublin

RECRUITING

Research Site, Poznan

RECRUITING

Research Site, Rzesz W

RECRUITING

Research Site, Warsaw

RECRUITING

Research Site, Wroclaw